The second French Community Innovation Survey (CIS) indicates that 14% of R&D collaborating firms had to abandon or delay their innovation projects due to difficulties in their partnerships, an outcome which we term “cooperation failures”. Controlling for sample selection on the cooperation...

This paper uses a survey of French firms active in R&D to identify the determinants of the trade-off between R&D subcontracting and R&D cooperation. We observe that R&D subcontracting is more likely than R&D cooperation when the partner is chosen on objective criteria, such as prices, quality...

[eng] This paper investigates how licensing between competitors can create significant barriers to competition. Several theoretical models have shown that licensing an innovation to a competitor can facilitate collusion, deter entry by more efficient firms or hinder technological progress. As a...

[eng] Patent and Drugs in Developing Countries. This article surveys the empirical literature on how patents affect access to drugs in developing countries. In the short run, higher prices and lower access rates are very likely, notably for those countries that benefited from a competitive...

This article analyzes the individual determinants of acquisition activity and target choices in the pharmaceutical industry over the period 1978-2002. The "innovation gap" hypothesis states that acquiring firms lack promising drug compounds and acquire firms with more promising drug prospects. A...

Although research and development (R&D) networks influence the innovation performance of their members, firms may not be fully aware of the scope of their network. In particular, due to cost reasons, they may not be fully informed of their “indirect ties”, that is, of the ties between their...

This article analyzes the individual determinants of acquisition activity and target choices in the pharmaceutical industry over the period 1978-2002. The "innovation gap" hypothesis states that acquiring firms lack promising drug compounds and acquire firms with more promising drug prospects. A...

This article analyzes the individual determinants of acquisition activity and target choices in the pharmaceutical industry over the period 1978-2002. The "innovation gap" hypothesis states that acquiring firms lack promising drug compounds and acquire firms with more promising drug prospects. A...

This article surveys the empirical literature on how patents affect access to drugs in developing countries. In the short run, higher prices and lower access rates are very likely, notably for those countries that benefited from a competitive supply before the TRIPS agreement came into force....